BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Market Reports 📊 58 Reports
51. ROI in Pharmaceutical R&D: How to Halt the Decline
The global orphan drugs market should reach $315.6 billion by 2024 from $127.5 billion in 2017 at a compound annual growth rate (CAGR) of 13.8% for the forecast period of 2017 to 2024.
52. Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies should grow from $346 billion in 2019 to $490 billion by 2024, at a compound annual growth rate (CAGR) of 7.2% fro
53. Contract Manufacturing: Global Markets to 2023
The global market for contract manufacturing should grow from $2.0 trillion in 2018 to $2.7 trillion in 2023 with a compound annual growth rate (CAGR) of 6.6% from 2018 through 2023.
54. Neurology Market: A BCC Research Overview
The global market for neurology should grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.5% for the period of 2019-2024.
55. Global Stem Cell and Regenerative Therapy Market: A BCC Research Outlook
The global stem cell and regenerative medicines market should grow from $21.8 billion in 2019 to reach $55.0 billion by 2024 at a compound annual growth rate (CAGR) of 20.4% for the period of 2019-202
56. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
57. Chronic Kidney Disease: Global Markets and Technologies Through 2023
According to BCC Research global market for chronic kidney disease should grow from $79.0 billion in 2018 to reach $95.0 billion by 2023 at a compound annual growth rate of 3.8%.
58. Antihypertensives: Global Markets to 2023
The global market for antihypertensive drugs should grow from nearly $26.3 billion in 2018 to $27.8 billion by 2023 with a compound annual growth rate (CAGR) of 1.1% for the period of 2018-2023.